Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease

Olorunfemi A. Oshagbemi, Andrea M. Burden, Kimberly N. Shudofsky, Johanna H. M. Driessen, Peter Vestergaard, Andreas Krings, Frits M. E. Franssen, Joop van den Bergh, Frank de Vries*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)238-243
Number of pages6
JournalBone
Volume110
DOIs
Publication statusPublished - May 2018

Keywords

  • COPD
  • Fracture
  • Glucocorticoids
  • Epidemiology
  • TRABECULAR BONE MICROARCHITECTURE
  • ORAL CORTICOSTEROIDS
  • INDUCED OSTEOPOROSIS
  • VERTEBRAL FRACTURES
  • MINERAL DENSITY
  • HIP FRACTURE
  • THERAPY
  • MECHANISMS
  • SEVERITY
  • DENMARK

Cite this